GlassScriptPhysician profile
Cooper Ching Chao
NPI 1609818608
$800.66
in general payments reported to CMS, 2019-2025
10 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $122 · 2023: $494 · 2024: $184.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $653 · Education: $25.59.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $653.16 |
| Education | $25.59 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Takeda Pharmaceuticals U.S.A., INC. | $213.98 | 2022-2024 | Entyvio |
| Janssen Biotech, INC. | $202.57 | 2022-2024 | Stelara |
| Qol Medical, LLC | $167.84 | 2022-2023 | Sucraid |
| Abbvie INC. | $48.97 | 2023 | Linzess |
| Nestle Healthcare Nutrition INC. | $48.79 | 2023 | |
| Intercept Pharmaceuticals, INC. | $28.17 | 2023 | Ocaliva |
| Celltrion USA INC. | $25.59 | 2024 | Zymfentra |
| Merck Sharp & Dohme LLC | $23.86 | 2024 | Dificid |
| Genzyme Corporation | $22.36 | 2023 | |
| Phathom Pharmaceuticals, INC. | $18.53 | 2024 | Voquezna |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Cooper Chao listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.